PITTSBURGH-A University of Pittsburgh research team created a synthetic anticancer molecule remarkably more powerful than current cancer drugs that could, once fully developed, offer an alternative to people whose cancer does not respond to available medication. The “Journal of the American Chemical Society” published the researchers’ account of developing the molecule, known as meayamycin, online Feb. 6 with the print version to come out next month. More testing is needed to perfect meayamycin, but the project’s lead investigator is optimistic that the powerful molecule will yield an effective treatment.>>> Discuss This Story
